MSD announces agreement to provide Singapore with antiviral drug molnupiravir for COVID-19 treatment | Video
Pharmaceutical company MSD announced on Wednesday (Oct 6) that it has entered a supply and purchase agreement with Singapore to provide molnupiravir, an investigational antiviral drug to treat COVID-19, if it is authorised or approved. Sherlyn Seah reports.
Pharmaceutical company MSD announced on Wednesday (Oct 6) that it has entered a supply and purchase agreement with Singapore to provide molnupiravir, an investigational antiviral drug to treat COVID-19, if it is authorised or approved. Sherlyn Seah reports.